secwatch / observer
8-K filed September 12, 2024, 7:59 PM ET ticker DTIL CIK 0001357874
leadership confidence high sentiment neutral materiality 0.70

Precision BioSciences names Murray Abramson SVP Clinical Development, John Fry as HBV Advisor; CMO List retires

PRECISION BIOSCIENCES INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alan List

Chief Medical Officer
DTIL · PRECISION BIOSCIENCES INC
Effective
2024-09-13
Filed
September 12, 2024, 7:59 PM ET
On September 9, 2024, Alan List, M.D., the Company’s Chief Medical Officer, notified Precision BioSciences, Inc. (the “Company”) that he will be retiring from the Company, effective September 13, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Alan List departed as Chief Medical Officer at PRECISION BIOSCIENCES INC.

Action
will be retiring
Role
Chief Medical Officer
Exact text from the filing
On September 9, 2024, Alan List, M.D., the Company’s Chief Medical Officer, notified Precision BioSciences, Inc. (the “Company”) that he will be retiring from the Company, effective September 13, 2024.
View on SEC.gov

PRECISION BIOSCIENCES INC filing history →

Source: SEC EDGAR
accession 0000950170-24-105706
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.